Nyxoah S.A. (NASDAQ:NYXH) Receives Average Recommendation of “Buy” from Brokerages

Nyxoah S.A. (NASDAQ:NYXHGet Rating) has been given a consensus rating of “Buy” by the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $31.00.

NYXH has been the subject of a number of research reports. Wolfe Research initiated coverage on shares of Nyxoah in a research report on Tuesday, April 5th. They set a “market perform” rating and a $21.00 target price for the company. Oppenheimer started coverage on shares of Nyxoah in a research report on Wednesday, April 20th. They issued an “outperform” rating and a $30.00 target price on the stock. Piper Sandler cut their price target on shares of Nyxoah from $40.00 to $30.00 in a report on Friday, March 25th. Finally, Zacks Investment Research lowered shares of Nyxoah from a “buy” rating to a “hold” rating in a research note on Friday, April 1st.

NYXH opened at $16.40 on Friday. Nyxoah has a 1-year low of $16.40 and a 1-year high of $37.00. The company has a quick ratio of 12.07, a current ratio of 12.10 and a debt-to-equity ratio of 0.07. The company has a fifty day moving average price of $18.80 and a two-hundred day moving average price of $20.70.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Credit Suisse AG purchased a new position in shares of Nyxoah during the 3rd quarter valued at approximately $221,000. Jane Street Group LLC purchased a new stake in Nyxoah in the 3rd quarter valued at about $228,000. Evolutionary Tree Capital Management LLC purchased a new stake in Nyxoah during the third quarter worth about $1,126,000. Monashee Investment Management LLC acquired a new position in shares of Nyxoah during the third quarter worth about $1,719,000. Finally, Rossmore Private Capital grew its position in shares of Nyxoah by 29.7% during the fourth quarter. Rossmore Private Capital now owns 117,940 shares of the company’s stock worth $2,494,000 after buying an additional 27,000 shares in the last quarter. 10.75% of the stock is owned by institutional investors.

Nyxoah Company Profile (Get Rating)

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Further Reading

Analyst Recommendations for Nyxoah (NASDAQ:NYXH)

Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.